Keywords: سرطان پستان HER2 مثبت است; HER2-Positive breast cancer; Biosimilars; Anti-HER2 therapy; Trastuzumab;
مقالات ISI سرطان پستان HER2 مثبت است (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells
Keywords: سرطان پستان HER2 مثبت است; HER2-Positive breast cancer; Lapatinib resistance; Phosphoproteomics; PAK2;
DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction
Keywords: سرطان پستان HER2 مثبت است; Cdc37; DCZ3112; Geldanamycin; Hsp90; HER2-positive breast cancer;
De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance
Keywords: سرطان پستان HER2 مثبت است; HER2-positive breast cancer; HER2-targeted therapy resistance; Oncogenic addiction; PI3K/PTEN; Estrogen receptor; Tumor microenvironment;
Impact of molecular and histological subtype of breast cancer on 18FDG-PET/CT imaging: Knowledge gained from recent studies
Keywords: سرطان پستان HER2 مثبت است; PET/CT; 18FDG; Breast cancer; Staging; Prognosis; Neoadjuvant chemotherapy; Response assessment; Pathological complete response; Triple-negative breast cancer; HER2-positive breast cancer; ER-positive breast cancerTEP/TDM; 18FDG; Cancer du sein; Bilan ini
Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer - An observational study prospectively recording resource utilization in a Swedish healthcare setting
Keywords: سرطان پستان HER2 مثبت است; HER2-positive breast cancer; Trastuzumab; Subcutaneous; Intravenous; Resource use; Societal cost; CPI; Consumer Price Index; HER2; Human Epidermal growth factor Receptor-2; IV; Intravenous; SC; Subcutaneous; SEK; Swedish Kronor; WTP; Willingness-to-Pay;
The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression
Keywords: سرطان پستان HER2 مثبت است; FOXF2; DNA methylation; Epithelial-to-mesenchymal transition; Basal-like/triple-negative breast cancer; Luminal breast cancer; HER2-positive breast cancer;
Proliferation Determined by Ki-67 Defines Different Pathologic Response to Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer
Keywords: سرطان پستان HER2 مثبت است; HER2-positive breast cancer; Ki-67 marker; Neoadjuvant trastuzumab-based chemotherapy; Pathologic complete response; Predictive factor
Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib
Keywords: سرطان پستان HER2 مثبت است; FW-04-806; HER2; HER3; HER2-positive breast cancer;
n-3 polyunsaturated fatty acids and HER2-positive breast cancer: Interest of the fat-1 transgenic mouse model over conventional dietary supplementation
Keywords: سرطان پستان HER2 مثبت است; n-3 fatty acids; Fat-1 transgenic mouse model; HER2-positive breast cancer;
C-FLIP(L) contributes to TRAIL resistance in HER2-positive breast cancer
Keywords: سرطان پستان HER2 مثبت است; HER2-positive breast cancer; TRAIL resistance; C-FLIP(L); Apoptosis;
All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer – A phase II study
Keywords: سرطان پستان HER2 مثبت است; HER2-positive breast cancer; Brain metastases; Lapatinib; Capecitabine
Treatment of HER2-positive breast cancer
Keywords: سرطان پستان HER2 مثبت است; HER2-positive breast cancer; Trastuzumab; Pertuzumab; Lapatinib;
Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer
Keywords: سرطان پستان HER2 مثبت است; Targeted therapy; Combination approaches; HER2-positive breast cancer; Trastuzumab resistance;
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial
Keywords: سرطان پستان HER2 مثبت است; Circulating tumor cells; pCR; HER2-positive breast cancer; Trastuzumab; Lapatinib;
Les anticorps conjugués en oncologie : du concept au trastuzumab emtansine (T-DM1)
Keywords: سرطان پستان HER2 مثبت است; trastuzumab emtansine; cancer du sein HER2-positif; réponse objective; bénéfice clinique; tolérance; trastuzumab emtansine; HER2-positive breast cancer; objective response; clinical benefit; safety;
The Effect of Early Detection of Occult Brain Metastases in HER2-Positive Breast Cancer Patients on Survival and Cause of Death
Keywords: سرطان پستان HER2 مثبت است; HER2-positive breast cancer; MRI screening; Occult brain metastases; WBRT;